OptimizeRX (OPRX) PT Lowered to $12 at Stifel, Buy Rating Maintained

August 13, 2026 9:00 AM

(Updated - August 13, 2026 10:21 AM EDT)

Stifel analyst David Grossman lowered the price target on OptimizeRX (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found